Literature DB >> 18841019

Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer's disease risk.

Ignacio Mateo1, Pascual Sánchez-Juan, Eloy Rodríguez-Rodríguez, Jon Infante, José Luis Vázquez-Higuera, Inés García-Gorostiaga, José Berciano, Onofre Combarros.   

Abstract

Oxidative stress plays a role in tau hyperphosphorylation and the development of neurofibrillary tangles (NFT). In Alzheimer's disease (AD) brain, accumulation of hyperphosphorylated tau in NFT is associated with the induction of heme oxygenase-1 (HO-1), a potent antioxidant that downregulates the production of tau. In a case-control study of 300 AD patients and 360 healthy controls, we examined whether the combined gene effects between HO-1 (-413, rs2071746) and tau (5' of exon 1, rs242557) polymorphisms might be responsible for susceptibility to AD. Subjects carrying both the HO-1 (-413) TT and the tau (5' of exon 1) AA genotypes had a more than 6.5-time higher risk of developing AD than subjects without these risk genotypes (OR = 6.65, 95% CI 1.12-39.29; p = 0.037). These data support a role for tau-related genes in the risk of AD. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841019     DOI: 10.1159/000161059

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

Review 1.  The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.

Authors:  Futao Zhou; Danli Wang
Journal:  Oncotarget       Date:  2017-06-27

2.  Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.

Authors:  Alexander J Gill; Rolando Garza; Surendra S Ambegaokar; Benjamin B Gelman; Dennis L Kolson
Journal:  J Neuroinflammation       Date:  2018-03-06       Impact factor: 8.322

3.  Heme oxygenase-1 promoter (GT) n polymorphism associates with HIV neurocognitive impairment.

Authors:  Rolando Garza; Alexander J Gill; Brandon L Bastien; Yoelvis Garcia-Mesa; Analise L Gruenewald; Benjamin B Gelman; Billy Tsima; Robert Gross; Scott L Letendre; Dennis L Kolson
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-04-10

Review 4.  Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

Authors:  Benoît Leclerc; Abedelnasser Abulrob
Journal:  ScientificWorldJournal       Date:  2013-02-05

5.  Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.

Authors:  Pu Song; Kai Li; Ling Liu; Xiaowen Wang; Zhe Jian; Weigang Zhang; Gang Wang; Chunying Li; Tianwen Gao
Journal:  J Cell Mol Med       Date:  2016-05-25       Impact factor: 5.310

Review 6.  Heme Oxygenase 1 in the Nervous System: Does It Favor Neuronal Cell Survival or Induce Neurodegeneration?

Authors:  Mariapaola Nitti; Sabrina Piras; Lorenzo Brondolo; Umberto Maria Marinari; Maria Adelaide Pronzato; Anna Lisa Furfaro
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

Review 7.  The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.